Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe
FDA approves Genentech’s sNDA for influenza therapy in children
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial
Traditional device start-ups catch the cash
*please scroll down for all the latest news*
